Kabir et al.
JOCArticle
iodide 8 (140 mg, 0.27 mmol), 2-isopropylbenzenethiol (48.7 mg,
0.32 mmol), CuI (5.2 mg, 0.027 mmol), 1,2-cis-cyclohexanediol
(6.3 mg, 0.054 mmol), K3PO4 (86 mg, 0.41 mmol), and DMF
(2.0 mL) were stirred at 30-40 °C to obtain the thioether 30 (78 mg,
96% yield) as a colorless oil. Column chromatography solvent
(2-3% EtOAc in hexane) provided pure 30. 1H NMR (300 MHz,
CDCl3): δ 7.45-7.21 (3H, m), δ 6.82 (1H, d, J = 14.8 Hz), δ
6.47-6.37 (4H, m), δ 6.31 (1H, t, J=2.1 Hz), δ 5.05 (1H, br s), δ
(300 MHz, CDCl3): δ 6.76 (1H, d, J=15.6 Hz), δ 6.49-6.40 (3H,
m), δ 6.29 (1H, t, J=2.1 Hz), δ 4.84 (1H, s), δ 3.80 (3H, s), δ
3.06-2.92 (1H, m), δ 2.08-1.65 (5H, m), δ 1.48-128 (5H, m).
13C NMR (75 MHz, CDCl3): δ 156.6, 139.4, 127.7, 125.1, 105.0,
104.1, 101.5, 100.1, 55.3, 45.2, 33.5, 25.9, 25.5. HRMS (ESI)
(M þ H)þ: calcd for C15H21O2S 265.1262, found 265.1265.
(E)-3-[2-(Benzothiazol-2-ylsulfanyl)vinyl]-5-methoxyphenol (35)
(Table 4, Entry 10). General procedure B was followed (8 h). Vinyl
iodide 8 (140 mg, 0.27 mmol), benzothiazole-2-thiol (53.5 mg,
0.32 mmol), CuI (5.1 mg, 0.027 mmol), 1,2-cis-cyclohexanediol
(6.3 mg, 0.054 mmol), K3PO4 (86 mg, 0.41 mmol) and DMF
(2.0 mL) were stirred at 50-60 °C to obtain the thioether 35
(78 mg, 92% yield) as a light yellow solid. Column chromatogra-
phy solvent (10% EtOAc in hexane) provided pure 35. Mp:
137.6-142.2 °C. 1H NMR (300 MHz, CD3OD): δ 7.93-7.86
(2H, m), δ7.50 (1H, t, J=7.2 Hz), δ7.41-7.28 (2H, m), δ7.05 (1H,
d, J=15.4 Hz), δ6.60 (2 H, d, J=6.1 Hz), δ6.38 (1H, d, J=2.2 Hz),
3.80 (3H, s). 13C NMR (75 MHz, CDCl3): δ 166.5, 160.2, 157.7,
152.1, 137.4, 136.2, 133.9, 125.1, 123.3, 119.9, 115.1, 104.8, 102.4,
100.7, 100.0, 53.2. HRMS (ESI) (M þ H)þ: calcd for C16H14-
NO2S2 316.0466, found 316.0465.
3.80 (3H, s), δ 3.52-3.48 (1H, m), δ 1.27 (6H, d, J=6.8 Hz). 13
C
NMR (75 MHz, CDCl3): δ 160.9, 156.7, 148.8, 144.5, 138.9, 131.9,
129.6, 128.0, 126.5, 125.8, 125.5, 105.3, 104.2, 100.6, 55.3, 30.5, 23.4.
HRMS (ESI) (M þ H)þ: calcd for C18H21O2S 301.1262, found
301.1260.
(E)-2-[2-(3-Hydroxy-5-methoxyphenyl)vinylsulfanyl]benzoic
Acid Methyl Ester (31) (Table 4, Entry 6). General procedure B
was followed (30 min). Vinyl iodide 8 (100 mg, 0.19 mmol),
benzenethiol-2-carboxylic acid methyl ester (38 mg, 0.23 mmol),
CuI (3.7 mg, 0.019 mmol), 1,2-cis-cyclohexanediol (4.4 mg,
0.038 mmol), K3PO4 (60 mg, 0.28 mmol), and DMF (2.0 mL)
were stirred at 30-40 °C to obtain the thioether 31 (50 mg, 83%
yield) as a colorless oil. Column chromatography solvent
(2-3% EtOAc in hexane) provided pure 31. 1H NMR (300
MHz, CDCl3): δ 8.01 (1H, d, J=7.8 Hz), δ 7.46-7.38 (2H, m), δ
7.28-7.22 (1H, m), δ 6.97 (1H, d, J=15.4 Hz), δ 6.88 (1H, d, J=
15.4 Hz), δ 6.60-6.57 (2H, m), δ 6.40 (1H, t, J=2.2 Hz) δ 4.01
(1H, s), δ 3.97 (3H, s), δ 3.82 (3H, s); 13C NMR (75 MHz,
CDCl3): δ 161.1, 157.0, 140.9, 138.4, 136.1, 132.5, 131.2, 127.5,
125.8, 124.9, 122.1, 108.3, 105.9, 104.8, 101.3, 55.3, 52.3. HRMS
(ESI) (M þ H): calcd for C17H17O4S 317.0848, found 317.0850.
(E)-3-Methoxy-5-[2-(naphthalen-2-ylsulfanyl)vinyl]phenol (32)
(Table 4, Entry 7). General procedure B was followed (1-2 h).
Vinyl iodide 8 (100 mg, 0.19 mmol), 2-naphthylthiol (37 mg, 0.23
mmol), CuI (3.7 mg, 0.019 mmol), 1,2-cis-cyclohexanediol (4.4
mg, 0.038 mmol), K3PO4 (60 mg, 0.28 mmol), and DMF (2.0 mL)
were stirred at 30-40 °C to obtain the thioether 32 (54 mg, 92%
yield) as a colorless oil. Column chromatography solvent (2-3%
EtOAc in hexane) provided pure 32. 1H NMR (300 MHz,
CDCl3): δ 7.89-7.79 (4H, m), δ 7.53-7.49 (3H, m), δ 6.97 (1H,
d, J=15.4 Hz), δ 6.67 (1H, d, J=15.4 Hz), δ 6.51 (1H, t, J=1.6
Hz), δ 6.46 (1H, t, J=1.9 Hz), δ 6.34 (1H, t, J=2.2 Hz), δ 4.90
(1H, s, b), δ 3.80 (3H, s); 13C NMR (75 MHz, CDCl3): δ 161.1,
156.8, 138.7, 133.7, 132.2, 131.1, 128.7, 128.4, 127.7, 127.2, 126.6,
126.1. 124.3, 105.4, 104.4, 100.9, 55.3. HRMS (EI): calcd for
C19H16O2S 308.0871, found 308.0851.
(E)-3-Methoxy-5-[2-(pyrimidin-2-ylsulfanyl)vinyl]phenol (36)
(Table 4, Entry 11). General procedure B was followed (8 h).
Vinyl iodide 8 (140 mg, 0.27 mmol), pyrimidine-2-thiol (35.9 mg,
0.32 mmol), CuI (5.1 mg, 0.027 mmol), 1,2-cis-cyclohexanediol
(6.3 mg, 0.054 mmol), K3PO4 (86 mg, 0.41 mmol), and DMF
(2.0 mL) were stirred at 50-60 °C to obtain the thioether 36 (61
mg, 87% yield) as an yellow solid. Column chromatography
solvent (10% EtOAc in hexane) provided pure 36. Mp:
1
107.1-110.2 °C. H NMR (300 MHz, CDCl3): δ 8.59 (2H, d,
J=4.8 Hz), δ 7.56 (1H, d, J=16.0 Hz), δ 7.06 (1H, t, J=4.9 Hz),
δ 6.75 (1H, d, J=16.0 Hz), δ 6.55 (2H, d, J=1.6 Hz), δ 6.35 (1H,
t, J=2.2 Hz) δ 6.09 (1H, s), δ 3.81 (3H, s). 13C NMR (75 MHz,
CDCl3): δ 160.9, 157.5, 157.0 138.4, 131.1, 119.9, 117.2, 106.7,
105.8, 104.6, 101.2, 55.3. HRMS (ESI) (M þ H)þ: calcd for
C13H13N2O2S 261.0698, found 261.0696.
(E)- 3-Methoxy-5-[2-(pyridin-2-ylsulfanyl)vinyl]phenol (37)
(Table 4, Entry 12). General procedure was B followed (4 h).
Vinyl iodide 8 (100 mg, 0.19 mmol), pyridine-2-thiol (25 mg,
0.23 mmol), CuI (3.7 mg, 0.019 mmol), 1,2-cis-cyclohexanediol
(4.4 mg, 0.038 mmol), K3PO4 (60 mg, 0.28 mmol), and DMF
(2.0 mL) were stirred at 40-50 °C to obtain the thioether 37 (45
mg, 92% yield) as a colorless solid. Column chromatography
1
solvent (10% EtOAc in hexane) provided pure 37. H NMR
(E)- 3-Methoxy-5-[2-(naphthalen-1-ylsulfanyl)vinyl]phenol (33)
(Table 4, Entry 8). General procedure B was followed (1-2 h).
Vinyl iodide 8 (100 mg, 0.19 mmol), 1-naphthylthiol (37 mg, 0.23
mmol), CuI (3.7 mg, 0.019 mmol), 1,2-cis-cyclohexanediol (4.4
mg, 0.038 mmol), K3PO4 (60 mg, 0.28 mmol), and DMF (2.0 mL)
were stirred at 30-40 °C to obtain the thioether 33 (53 mg, 91%
yield) as a colorless oil. Column chromatography solvent (2-3%
EtOAc in hexane) provided pure 33. 1H NMR (300 MHz,
CDCl3): δ 8.38 (1H, d, J=8.3 Hz), δ 7.93-7.85 (2H, m), δ 7.72
(1H, d, J=7.2 Hz), δ 7.60-7.56 (2H, m), δ 7.51-7.45 (1H, m), δ
6.87 (1H, t, J=15.4 Hz), δ 6.49 (1H, d, J=15.4 Hz), δ 6.43 (1H, s),
δ 6.37 (1H, s), δ 6.30 (1H, t, J=2.2 Hz), δ 5.16 (1H, s) δ 3.76 (3H,
s); 13C NMR (75 MHz, CDCl3): δ 161.0, 156.7, 138.8, 134.0,
130.4, 129.9, 128.9, 128.7, 128.5, 128.2, 126.8, 126.4, 125.7, 125.2,
125.1, 105.3, 104.3, 100.7, 55.3. HRMS (ESI) (M þ H)þ: calcd for
C19H17O2S 309.0949, found 309.0952.
(E)- 3-(2-Cyclohexylsulfanylvinyl)-5-methoxyphenol (34)
(Table 4, Entry 9). General procedure B was followed (4 h).
Vinyl iodide 8 (140 mg, 0.27 mmol), cyclohexanethiol (37.2 mg,
0.32 mmol), CuI (5.1 mg, 0.027 mmol), 1,2-cis-cyclohexanediol
(6.3 mg, 0.054 mmol), K3PO4 (86 mg, 0.41 mmol), and DMF
(2.0 mL) were stirred at 40-50 °C to obtain the thioether 34 (69
mg, 96% yield) as a colorless oil. Column chromatography
solvent (3-5% EtOAc in hexane) provided pure 34. 1H NMR
(300 MHz, CDCl3): δ 8.50 (1H, d, J=5.0 Hz), δ 7.59 (1H, t, J=
7.8 Hz), δ 7.38 (1H, d, J=15.8 Hz), δ 7.29-7.27 (1H, m), δ
7.12-7.08 (1H, m), δ 6.77 (1H, d, J=15.8 Hz) δ 6.51 (2H,d, J=
2.1 Hz), δ 6.34 (1H, t, J=2.1 Hz), δ 6.14 (1H, br s), δ 3.79 (3H, s);
13C NMR (75 MHz, CDCl3): δ 160.9, 157.9, 157.0, 149.6, 138.5,
136.6, 132.3, 122.3, 120.4, 120.0, 105.8, 104.5, 101.2, 55.2.
HRMS (ESI) (M þ H)þ: calcd for C14H14NO2S 260.0745, found
260.0744.
(E)- 3-Methoxy-5-[2-(thiophene-2-ylsulfanyl)vinyl]phenol (38)
(Table 4, Entry 13). General procedure B was followed (4 h).
Vinyl iodide 8 (100 mg, 0.19 mmol), 2-thiothiophene (27 mg,
0.23 mmol), CuI (3.7 mg, 0.019 mmol), 1,2-cis-cyclohexanediol
(4.4 mg, 0.038 mmol), K3PO4 (60 mg, 0.28 mmol), and DMF
(2.0 mL) were stirred at 40-50 °C to obtain the thioether 38 (43
mg, 86% yield) as a colorless solid. Column chromatography
1
solvent (10% EtOAc in hexane) provided pure 38. H NMR
(300 MHz, CDCl3): δ 7.47 (1H, m), δ 7.25 (1H, dd, J=3.6, 1.3
Hz), δ 7.08 (1H, dd, J=5.3, J=3.6 Hz), δ 6.75 (1H, d, J=15.4
Hz), δ 6.43-6.35 (3H, m), δ 6.30 (1H, t, J=2.2 Hz), δ 5.21 (1H,
s), δ 3.78 (3H, s). 13C NMR (75 MHz, CDCl3): δ 160.9, 156.7,
138.5, 134.1, 130.3, 127.9, 127.8, 127.0, 125.3, 105.4, 104.3,
100.7, 55.3. HRMS (ESI) (M þ H)þ: calcd for C13H13O2S2
265.0357, found 265.0363.
J. Org. Chem. Vol. 75, No. 11, 2010 3641